Stocks traded mixed on Tuesday after U.S. federal health officials called for a pause in the rollout of Johnson & Johnson’s (JNJ) COVID-19 vaccine amid concerns over rare blood clots in some individuals who received the inoculation.

[Click here to read what’s moving markets heading into Wednesday, April 14]

The Dow dipped, extending losses from the pre-market session following the joint announcement between the U.S. Food and Drug Administration and Centers for Disease Control and Prevention, which could complicate the vaccine distribution process as the country paces toward achieving herd immunity. The Nasdaq gained as technology shares advanced, while the S&P 500 was little changed.

Shares of Dow component Johnson & Johnson also dipped following the report. According to the health agencies, more than 6.8 million doses of the single-dose vaccine had been administered in the U.S. so far. The agencies are reviewing data over six…

Read more…


Comments are closed.